Gregory F Egnaczyk
Overview
Explore the profile of Gregory F Egnaczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
915
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia S, Dowling R, Chung E, Egnaczyk G, Stewart-Dehner T, Answini G, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(5):101132.
PMID: 39132389
[This corrects the article DOI: 10.1016/j.jscai.2023.101044.].
2.
Garcia S, Dowling R, Chung E, Egnaczyk G, Stewart-Dehner T, Answini G, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(4):101044.
PMID: 39131634
No abstract available.
3.
Allen S, Slaughter M, Ahmed M, Bartoli C, Dhingra R, Egnaczyk G, et al.
J Heart Lung Transplant
. 2022 Nov;
42(1):33-39.
PMID: 36347767
Background: Continuous flow left ventricular assist devices have improved outcomes in patients with end-stage heart failure that require mechanical circulatory support. Current devices have an adverse event profile that has...
4.
Truong V, Egnaczyk G, OBrien T, Raymond T, Gilardi S, Shreenivas S, et al.
Am J Cardiol
. 2022 Jun;
177:61-68.
PMID: 35697544
The impact of substance abuse, including alcohol abuse or illicit drug use, on outcomes after left ventricular assist device (LVAD) implantation, has not been fully elucidated. Accordingly, to test the...
5.
Truong V, Shreenivas S, Mazur W, Egnaczyk G, Palmer C, Rao S, et al.
ASAIO J
. 2021 Apr;
68(2):220-225.
PMID: 33927084
The impact of preoperative end-diastolic left ventricular dimension (preLVEDD) on long-term outcomes with centrifugal continuous-flow left ventricular assist device (CF-LVAD) is not well established. Accordingly, we performed an analysis of...
6.
Truong V, Mazur W, Broderick J, Egnaczyk G, Kereiakes D, Sarembock I, et al.
J Am Soc Echocardiogr
. 2020 Aug;
33(11):1357-1362.e2.
PMID: 32828622
Background: The aim of this study was to examine the relationship between baseline left ventricular (LV) geometry and outcomes after transcatheter aortic valve replacement (TAVR). Methods: Patients undergoing TAVR (n ...
7.
Truong V, Mazur W, Palmer C, Egnaczyk G, Kereiakes D, Sarembock I, et al.
J Am Soc Echocardiogr
. 2019 Jul;
32(9):1067-1074.e1.
PMID: 31278049
Background: Left ventricular filling pressure (LVFP) has been demonstrated to be a major predictor of poor cardiovascular outcomes. However, estimation of LVFP in patients with aortic stenosis is limited by...
8.
Felker G, Mentz R, Cole R, Adams K, Egnaczyk G, Fiuzat M, et al.
J Am Coll Cardiol
. 2016 Sep;
69(11):1399-1406.
PMID: 27654854
Background: The oral vasopressin-2 receptor antagonist tolvaptan causes aquaresis in patients with volume overload, potentially facilitating decongestion and improving the clinical course of patients with acute heart failure (AHF). Objectives:...
9.
10.
Felker G, Mentz R, Adams K, Cole R, Egnaczyk G, Patel C, et al.
Circ Heart Fail
. 2015 Sep;
8(5):997-1005.
PMID: 26374918
Congestion is a primary reason for hospitalization in patients with acute heart failure (AHF). Despite inpatient diuretics and vasodilators targeting decongestion, persistent congestion is present in many AHF patients at...